NGM Historical Earnings image   This NGM historical earnings page last updated 3/13/2024
NGM Historical Revenue
PeriodHistorical Earnings DateGAAP
Q4 20233/11/20240.00B
Q3 202311/2/20230.00B
Q2 20238/3/20230.00B
Q1 20235/4/20230.00B
Q4 20222/28/20230.02B
Q3 202211/3/20220.01B
Q2 20228/4/20220.01B
Q1 20225/5/20220.02B
Q4 20213/1/20220.02B
Q3 202111/4/20210.02B
Q2 20218/5/20210.02B
Q1 20215/6/20210.02B
Q4 20203/4/20210.02B
Q3 202011/12/20200.02B
Q2 20208/12/20200.02B
Q1 20205/13/20200.02B
Q4 20193/17/20200.03B
Q3 201911/12/20190.02B
Q2 20198/12/20190.03B
Q1 20195/16/20190.03B
NGM Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q4 20233/11/2024-0.330
Q3 202311/2/2023-0.350
Q2 20238/3/2023-0.460
Q1 20235/4/2023-0.580
Q4 20222/28/2023-0.450
Q3 202211/3/2022-0.590
Q2 20228/4/2022-0.590
Q1 20225/5/2022-0.420
Q4 20213/1/2022-0.350
Q3 202111/4/2021-0.370
Q2 20218/5/2021-0.480
Q1 20215/6/2021-0.360
Q4 20203/4/2021-0.400
Q3 202011/12/2020-0.430
Q2 20208/12/2020-0.380
Q1 20205/13/2020-0.280
Q4 20193/17/2020-0.240
Q3 201911/12/2019-0.170
Q2 20198/12/2019-0.130
Q1 20195/16/2019-1.210
Quotes delayed 20 minutes

Email EnvelopeFree NGM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NGM Biopharmaceuticals (NGM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NKTR Historical Earnings
NKTX Historical Earnings
NLTX Historical Earnings
NMRA Historical Earnings
NMTC Historical Earnings
NMTR Historical Earnings
NOTV Historical Earnings
NOVN Historical Earnings
NPCE Historical Earnings
NRBO Historical Earnings
What was the record high NGM historical earnings result?
In terms of earnings or revenue, what is the best NGM historical earnings result that NGM Biopharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest NGM historical earnings result was set in Q2 2019, when NGM Biopharmaceuticals posted results of -0.130/share. The most successful revenue quarter within our data set was Q4 2019 when NGM Biopharmaceuticals reported revenue of 0.03B.

What was the lowest NGM Biopharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest NGM has reported, and when?

✔️Accepted answer: Within our data set, the lowest NGM historical earnings result was set in Q1 2019, when NGM Biopharmaceuticals posted results of -1.210/share. The smallest revenue quarter within our data set was Q4 2023 when NGM Biopharmaceuticals reported revenue of 0.00B.

On this page we presented the NGM historical earnings date information for NGM Biopharmaceuticals. Reviewing that NGM Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2019, when NGM posted gaap of -0.130/share. Meanwhile the lowest NGM historical earnings result was in Q1 2019, when NGM posted gaap of -1.210/share. Moving to NGM Biopharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2019 when NGM reported 0.03B in revenue, while the smallest revenue quarter was Q4 2023 when NGM reported 0.00B in revenue.

For self directed investors doing their due diligence on NGM or any other given stock, their research can benefit from looking into all of the NGM Biopharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into NGM Biopharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for NGM. Thanks for visiting, and the next time you need to research NGM historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding MRTX, DLA Price Target, OLP market cap history.

 

NGM Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.